{
    "SPADE_N_01396": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_01396",
            "Peptide Name": "Esculentin-2PRa (Frogs, amphibians, animals)",
            "Source": "Rana pretiosa (North American oregon spotted frog)",
            "Family": "Belongs to the frog skin active peptide family (Brevinin subfamily)",
            "Gene": "Not found",
            "Sequence": "GVFSFLKTGAKLLGSTLLKMAGKAGAEHLACKATNQC",
            "Sequence Length": 37,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-",
                "Antifungal"
            ],
            "Target Organism": "Gram-negative bacterium:Escherichia coli;Gram-positive bacterium:Staphylococcus aureus.Yeast:Candida albicans.",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "No cytotoxicity information found in the reference(s) presented",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Cyclic",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Cyclization (Cys31 and Cys37)",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C166H278N46O47S3",
            "Mass": 3766.46,
            "PI": 9.6,
            "Net Charge": 5,
            "Hydrophobicity": 0.31,
            "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour",
            "Function": "Shows antibacterial activity against both Gram-positive and Gram-negative bacteria and against the fungus C. albicans.",
            "Literature": [
                {
                    "Title": "Host defense peptides in skin secretions of the Oregon spotted frog Ranapretiosa implications for species resistance to chytridiomycosis.",
                    "Pubmed ID": "21295070",
                    "Reference": "Dev Comp Immunol. 2011 Jun;35(6)644-649.",
                    "Author": "Conlon JM, Mechkarska M, Ahmed E, Coquet L, Jouenne T, Leprince J, Vaudry H, Hayes MP, Padgett-Flohr G.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=21295070"
                }
            ],
            "Frequent Amino Acids": "ALG",
            "Absent Amino Acids": "DIOPRUWY",
            "Basic Residues": 6,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 16,
            "Polar Residues": 22,
            "Positive Residues": 6,
            "Negative Residues": 1,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_07825",
                    "Similarity": 0.8108108108108109,
                    "Sequence": "GIFSALAAGVKLLGNTLFKMAGKAGAEHLACKATNQC"
                },
                {
                    "SPADE_ID": "SPADE_N_01340",
                    "Similarity": 0.7567567567567568,
                    "Sequence": "GIFSLFKAGAKFFGKHLLKQAGKAGAEHLACKATNQC"
                },
                {
                    "SPADE_ID": "SPADE_N_01362",
                    "Similarity": 0.7567567567567568,
                    "Sequence": "NIFSLLSLGAKVLGKTLLKSAGKAGAEQLACKATNQC"
                }
            ]
        }
    }
}